Kidney Function Test Market Size is valued at USD 863.35 Mn in 2022 and is predicted to reach USD 1,458.50 Mn by the year 2031 at a 6.08% CAGR during the forecast period for 2023-2031.
The kidneys are essential organs that filter blood and remove waste products and excess fluids from the body, so tests that measure kidney function are in high demand. These tests can aid in diagnosing conditions like chronic kidney disease, acute kidney injury, kidney stones, and urinary tract infections (UTIs). The market is likely to expand because the growth in the test market is expected to be greatly boosted during the anticipated period as a result of increasing access to at-home kidney function testing and theorizing R&D initiatives for the general expansion of fresh goods.
Increases in chronic renal illness, the need for more accurate kidney function testing, quick diagnostic improvements, and other factors are driving the industry forward. Furthermore, major contributors to the worldwide increase in chronic renal disease are diabetes and higher blood pressure. The market is expected to slow down during the projection period as a result of rising diabetes rates.
However, the market growth is hampered in the long run, and the global demand for these renal medications may slow the market's expansion. Loss of appetite, fever, and rashes are just a few side effects that could slow down the market. Changes in blood tests may also indicate liver and kidney problems, as well as an uncommon but serious side effect of a drop in blood cell levels. Therefore, market obstacles are caused by these reasons.
The COVID-19 pandemic exerted a profound and extensive influence on the healthcare system. Patients with COVID-19 typically exhibit abnormalities in their kidneys, including elevated levels of protein or blood in their urine. Adults with COVID-19 have been found to suffer from acute renal damage and subsequent loss of kidney function.
Competitive Landscape
Some Major Key Players In The Kidney Function Test Market:
- Beckman Coulter (US)
- Siemens (Germany)
- Nova Biomedical (US)
- Roche (Switzerland)
- Abbott (US)
- URIT Medical (China)
- ARKRAY (Japan)
- OPTI Medical (US)
- ACON Laboratories (US)
- Sysmex (Japan)
- 77 Elektronika (Hungary)
- Randox Laboratories (UK)
- Quest Diagnostics
- Others
Market Segmentation:
The Kidney Function Test Market is segmented based on Product, Type And End-User. The Product segment consists of dipsticks, reagents, and disposables. By type, the market is divided into urine tests and blood tests, in which urine tests include Urine Protein, Microalbumin, and creatinine Clearance. At the same time, Blood Test consists of Serum Creatinine Tests, Glomerular Filtration Rate Tests, and Blood Urea Nitrogen Tests. Lastly, By End-User, the market is divided into Hospitals, Diagnostics Laboratories, Research Laboratories and Institutes.
Based On The Product, The Dipsticks Kidney Function Test Market Segment Is Accounted As A Major Contributor To The Kidney Function Test Market.
The dipstick segment is projected to grow rapidly in the global kidney function test market. Dipsticks is expected to hold a major global market share in 2022. Dipsticks are useful for diagnosing various kidney and urinary tract issues, including chronic kidney disease, acute kidney injury, bladder illness, and kidney stones, especially in countries like the US, Germany, the UK, China, and India.
Serum Creatinine Segment To Witness Growth At A Rapid Rate.
The serum creatinine segment is projected to grow rapidly in the global kidney function test market because it shows how well the kidneys are at filtering waste from the blood. It is a crucial marker of kidney health, especially in countries like the US, Germany, the UK, China, and India.
In The Region, The Asia Pacific Kidney Function Test Market Holds A Significant Revenue Share.
The Asia Pacific kidney function test market is expected to record the maximum market share in revenue in the near future. Because of the large number of government programs showing support and the consistent implementation by healthcare organizations in the region, the test market is expected to be stable over the anticipated time. In addition, Europe is estimated to grow rapidly in the global kidney function test market because of the widespread existence of generic manufacturers and the expanding awareness activities of government and pharmaceutical groups. Rapidly rising investment in research and development by market participants is another factor driving expansion.
Recent Developments:
- In Sept 2022, The UF-1500 Fully Automated Urine Particle Analyzer (UF-1500) was introduced by Sysmex. The UF-1500 inherits the UF-5000 Fully Automated Urine Particle Analyzer's (UF-5000) high levels of functionality and usability. With the expansion of its product line, will provide a broader selection of solutions tailored to the customer's environment and contribute to the simplification and standardisation of urine testing in small and medium-sized facilities.
- In March 2022, Nova Biomedical introduced a new device to enhance renal care through screening for kidney function and rapid detection of kidney disease in outpatient settings. The new Nova Max Pro Creatinine/eGFR Metre System featured a simplified metre and creatinine biosensor that measured blood creatinine and estimated glomerular filtration rate (eGFR) from a tiny 1.2 microliter capillary fingerstick blood sample in just 30 seconds. These are two important indicators of overall kidney function.
Kidney Function Test Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2022 |
USD 863.35 Mn |
|
Revenue Forecast In 2031 |
USD 1,458.50 Mn |
|
Growth Rate CAGR |
CAGR of 6.08% from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Mn and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product, By Type, By End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Beckman Coulter (US), Siemens (Germany), Nova Biomedical (US), Roche (Switzerland), Abbott (US), URIT Medical (China), ARKRAY (Japan), OPTI Medical (US), ACON Laboratories (US), Sysmex (Japan), 77 Elektronika (Hungary), and Randox Laboratories (UK) |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
